BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2024 10:41:21 AM | Browse: 444 | Download: 988
Publication Name World Journal of Gastroenterology
Manuscript ID 94490
Country Italy
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Microbiology
Manuscript Type Editorial
Article Title Aspergillus niger prolyl endopeptidase in celiac disease
Manuscript Source Invited Manuscript
All Author List Marica Colella, Concetta Cafiero and Raffaele Palmirotta
ORCID
Author(s) ORCID Number
Marica Colella http://orcid.org/0000-0003-0806-4327
Concetta Cafiero http://orcid.org/0000-0003-3859-2040
Raffaele Palmirotta http://orcid.org/0000-0002-9401-7377
Funding Agency and Grant Number
Corresponding Author Raffaele Palmirotta, MD, PhD, Associate Professor, Senior Researcher, Interdisciplinary Department of Medicine, Section of Microbiology and Virology,, University of Bari “Aldo Moro”, P.zza G. Cesare, 11, Bari 70124, Italy. raffaelepalmirotta@gmail.com
Key Words Celiac disease; Aspergillus niger prolyl endoprotease; Gluten immunogenic peptides; Trial; Symptoms; Real-life trial
Core Tip Involuntary or voluntary exposure to gluten in long-term gluten-free diet celiac patients could lead to severe and persistent symptoms. Aspergillus niger prolyl endopeptidase is able to metabolize gluten before it arrives into the small intestine, reducing the celiac disease-specific symptoms. It is demonstrated by the decrease in the concentration on gluten immunogenic peptide.
Publish Date 2024-06-25 10:41
Citation

Colella M, Cafiero C, Palmirotta R. Aspergillus niger prolyl endopeptidase in celiac disease. World J Gastroenterol 2024; 30(24): 3044-3047

URL https://www.wjgnet.com/1007-9327/full/v30/i24/3044.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i24.3044
Full Article (PDF) WJG-30-3044-with-cover.pdf